Meta-analysis of efficacy and safety of Qianliexin capsule combined with western medicine in benign prostatic hyperplasia treatmen
Journal Title: TMR Integrative Medicine - Year 2021, Vol 5, Issue 20
Abstract
Objective: To systematically evaluate the efficacy and safety of Qianliexin capsule combined with western medicine in benign prostatic hyperplasia treatment. Methods: Randomized controlled trials of Qianliexin capsule combined with western medicine in the treatment of benign prostatic hyperplasia were searched from PubMed, the Cochrane Library, EMBASE, Web of Science, China National Knowledge Infrastructure, VIP, Wanfang and China Biomedical Literature Databases from establishment of the database to February 2021. Meta-analysis was performed using RevMan5.4 software after two researchers independently screened the literatures, extracted the data and evaluated the bias risks in the included studies according to the Cochrane Collaboration System Evaluator Manual. Results: 6 randomized controlled trials involving 1060 patients were included. Meta-analysis results showed that the treatment group was better than the control group in total effective rate (Relative Risk = 1.19, 95% Confidence Interval (1.10, 1.28), P < 0.00001), International Prostate Symptom Score (Mean Difference = -2.99, 95% confidence interval (-4.00, -1.99) , P < 0.00001), prostate volume (Mean Difference = -3.77, 95% Confidence Interval (-4.67, -2.86), P < 0.00001), postvoid residual urine volume (Mean Difference = -5.96, 95% Confidence Interval (-8.15, -3.77), P < 0.00001) and maximum urine flow rate (Mean Difference = 3.45, 95% Confidence Interval (2.53, 4.37), P < 0.00001). While there was no significant difference in the adverse effects rate (Relative Risk = 0.71, 95% Confidence Interval (0.33, 1.56), P = 0.40) between the treatment group and the control group. Conclusion: Qianliexin capsule combined with western medicine in the treatment of benign prostatic hyperplasia showed good efficacy and high safety. However, more high-quality and large-sample studies are needed to confirm the above conclusions.
Authors and Affiliations
Sheng-Nan Wang, Yi-Hua Fan, Shan Lin, Jin-Rui Wei, Sheng-Xuan Zhao, Qiao Liu, Kai Zhong
Keywords
Related Articles
- EP ID EP697539
- DOI 10.53388/TMRIM202105020
- Views 65
- Downloads 0
Anti-fungal potency of some Unani drugs in the treatment of dermatophytoses (Qūba)
Qūba (dermatophytoses) is a clinical condition caused by fungal infection of skin in humans. The fungi that cause dermatophytoses feed on keratin, the material found in the outer layer of skin, hair and nails. Many effec...
Prognostic value of potential biomarkers in prostate cancer via bioinformatic analysis
Background: The Genotype-Tissue Expression was used to expanded normal tissue of the Cancer Genome Atlas database. This study aimed to investigate genes associated with the pathogenesis and prognosis of prostate cancer....
Guidance on home rehabilitation in Chinese and Western medicine to prevent the relapse of novel coronavirus disease-19 pneumonia after recovery
Patients with novel coronavirus disease-19 (COVID-19) pneumonia continue to have problems with respiratory function, physical and psychological function, the ability to perform activities of daily living, and social part...
Application of Chinese five-tone melodies combined with acupoint massage in reducing anxiety and depression levels of elderly
Background: To investigate the clinical efficacy of Chinese five-tone melodies combined with acupoint massage on anxiety and depression in elderly in Nursing home. Methods: The intervention music for 22 elderly participa...
A comparative study on the anti-bacterial effect of Echinops persicus, Cardamine uliginosa and Vaccaria oxyodontha Boiss on Staphylococcus aureus and Escherichia coli bacteria in vitro
Background: Medicinal herbs have always been closely associated with human beings, and no one deny their medicinal effects and uses. There are over 7,500 plant species in the rich flora of Iran. This study, intends to in...